Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis

Inclusion Criteria: * Patients of either sex between 12 and 70 years of age. * Patients with documented clinical history of SAR, for at least 2 years prior to the study inclusion. * Positive skin prick test for at least one of the seasonal allergen specific of the geographical area. * A previous positive Prick test, or a positive IgE Test (RAST) may also be accepted for inclusion, if performed within 12 months prior to the inclusion. Exclusion Criteria: * Patients who have non-allergic rhinitis (vasomotor, infectious, drug-induced, etc.). * Negative skin prick test (as defined in point 6.1.1.). * Patients with nasal polyps or a significant deviation of the nasal septum as judged by the investigator as well as nasal intervention in the previous 6 months. Any other nasal illness that can interfere with the aim of the study. * Patients who have acute or chronic sinusitis as judged by the investigator. * Patients who have received anti-allergy immunotherapy in the previous two years or are still receiving this kind of therapy. * Patients who are taking or have taken specified medications prior to randomisation in the study and have not complied with the specified washout period